Dupilumab‐associated head and neck dermatitis: Rapid response with abrocitinib treatment
Abstract Development or exacerbation of head and neck dermatitis (HN‐D) in association with dupilumab has been reported. Severity of HN‐D varies, and may persist even with discontinuation of dupilumab. Development or exacerbation of HN‐D is not yet completely understood, and various hypotheses have...
Saved in:
Main Authors: | , |
---|---|
Format: | Book |
Published: |
Wiley,
2024-02-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
Connect to this object online.3rd Floor Main Library
Call Number: |
A1234.567 |
---|---|
Copy 1 | Available |